Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-01-03 Simpson Curran SVP, Product Development & CTO Grant or award · Stock Option (Right to Buy) +46,000 46,000
2019-01-03 Danos Olivier Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +48,000 48,000
2019-01-03 Vasista Vittal Chief Financial Officer Grant or award · Stock Option (Right to Buy) +57,000 57,000
2019-01-03 Mills Kenneth T. President and CEO Grant or award · Stock Option (Right to Buy) +190,000 190,000
2018-12-31 Christmas Patrick J. SVP, General Counsel Grant or award +337 $35.66 $12K 3,006
2018-12-18 Christmas Patrick J. SVP, General Counsel Exercise or conversion +5,000 $12.10 $61K 7,669
2018-12-18 Christmas Patrick J. SVP, General Counsel Sale −2,225 $46.79 $104K 5,444
2018-12-18 Christmas Patrick J. SVP, General Counsel Sale −2,055 $47.85 $98K 3,389
2018-12-18 Christmas Patrick J. SVP, General Counsel Sale −720 $48.97 $35K 2,669
2018-12-18 Christmas Patrick J. SVP, General Counsel Exercise or conversion · Employee Stock Option (Right to Buy) −5,000 53,472
2018-12-17 Vasista Vittal Chief Financial Officer Sale −4,100 $45.73 $187K 125,683
2018-12-17 Vasista Vittal Chief Financial Officer Sale −1,700 $46.47 $79K 123,983
2018-12-17 Vasista Vittal Chief Financial Officer Sale −1,700 $47.74 $81K 122,283
2018-12-17 Mills Kenneth T. President and CEO Sale −7,604 $46.11 $351K 223,396
2018-12-17 Mills Kenneth T. President and CEO Sale −2,988 $46.81 $140K 220,408
2018-12-17 Mills Kenneth T. President and CEO Sale −4,408 $47.74 $210K 216,000
2018-12-03 Yoo Stephen Chief Medical Officer Exercise or conversion +20,414 $0.85 $17K 20,414
2018-12-03 Yoo Stephen Chief Medical Officer Sale −6,854 $59.62 $409K 13,560
2018-12-03 Yoo Stephen Chief Medical Officer Sale −13,053 $60.35 $788K 507
2018-12-03 Yoo Stephen Chief Medical Officer Sale −507 $61.20 $31K 0

Page 31 of 43 · 852 trades